Quest Diagnostics Incorporated announced that Chief Financial Officer Mark Guinanwill retire in 2022, and the process to find a successor is underway.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.8 USD | -0.48% | +1.50% | +0.63% |
03:04pm | Baird Adjusts Quest Diagnostics' Price Target to $144 From $138 | MT |
Apr. 29 | US FDA publishes final rule for laboratory developed tests | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.63% | 15.5B | |
-14.49% | 85.02B | |
+13.97% | 82.37B | |
+10.49% | 29.29B | |
-10.94% | 17.21B | |
-0.86% | 16.7B | |
+4.14% | 12.15B | |
-2.10% | 12.13B | |
+32.15% | 12.12B | |
-31.05% | 11.8B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Announces Mark Guinan Will Retire as Chief Financial Officer